|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Swerdlow SH, Campo E, Pileri SA, Harris
NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz
AD and Jaffe ES: The 2016 revision of the World Health Organization
classification of lymphoid neoplasms. Blood. 127:2375–2390. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Seo S, Hong JY, Yoon S, Yoo C, Park JH,
Lee JB, Park CS, Huh J, Lee Y, Kim KW, et al: Prognostic
significance of serum beta-2 microglobulin in patients with diffuse
large B-cell lymphoma in the rituximab era. Oncotarget.
7:76934–76943. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nowakowski GS and Vitolo U: Recent
advances in clinical studies and the evolving role of subtyping for
patients with diffuse large B-cell lymphoma. Future Oncol.
13:859–862. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Oki Y, Ewer MS, Lenihan DJ, Fisch MJ,
Hagemeister FB, Fanale M, Romaguera J, Pro B, Fowler N, Younes A,
et al: Pegylated liposomal doxorubicin replacing conventional
doxorubicin in standard R-CHOP chemotherapy for elderly patients
with diffuse large B-cell lymphoma: An open label, single arm,
phase II trial. Clin Lymphoma Myeloma Leuk. 15:152–158. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Friedberg JW: Relapsed/refractory diffuse
large B-cell lymphoma. Hematol Am Soc Hematol Educ Program.
2011:498–505. 2011.
|
|
7
|
Zhu L, Yang S, He S, Qiang F, Cai J, Liu
R, Gu C, Guo Z, Wang C, Zhang W, et al: Downregulation of
ubiquitin-specific protease 14 (USP14) inhibits breast cancer cell
proliferation and metastasis, but promotes apoptosis. J Mol Histol.
47:69–80. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Piao S, Liu Y, Hu J, Guo F, Ma J, Sun Y
and Zhang B: USP22 is useful as a novel molecular marker for
predicting disease progression and patient prognosis of oral
squamous cell carcinoma. PLoS One. 7:e425402012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sy SM, Jiang JO WS, Deng Y and Huen MS:
The ubiquitin specific protease USP34 promotes ubiquitin signaling
at DNA double-strand breaks. Nucleic Acids Res. 41:8572–8580. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Phillips AH, Zhang Y, Cunningham CN, Zhou
L, Forrest WF, Liu PS, Steffek M, Lee J, Tam C, Helgason E, et al:
Conformational dynamics control ubiquitin-deubiquitinase
interactions and influence in vivo signaling. Proc Natl Acad Sci
USA. 110:11379–11384. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zeng Z, Wu HX, Zhan N, Huang YB, Wang ZS,
Yang GF, Wang P and Fu GH: Prognostic significance of USP10 as a
tumor-associated marker in gastric carcinoma. Tumour Biol.
35:3845–3853. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y, Wang J, Zhong J, Deng Y, Xi Q, He
S, Yang S, Jiang L, Huang M, Tang C and Liu R: Ubiquitin-specific
protease 14 (USP14) regulates cellular proliferation and apoptosis
in epithelial ovarian cancer. Med Oncol. 32:3792015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Yao L, Zhang X, Ji H, Wang L, Sun
S and Pang D: Elevated expression of USP22 in correlation with poor
prognosis in patients with invasive breast cancer. J Cancer Res
Clin Oncol. 137:1245–1253. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lui TT, Lacroix C, Ahmed SM, Goldenberg
SJ, Leach CA, Daulat AM and Angers S: The ubiquitin-specific
protease USP34 regulates axin stability and Wnt/β-catenin
signaling. Mol Cell Biol. 31:2053–2065. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Engel E, Viargues P, Mortier M,
Taillebourg E, Couté Y, Thevenon D and Fauvarque MO: Identifying
USPs regulating immune signals in Drosophila: USP2 deubiquitinates
Imd and promotes its degradation by interacting with the
proteasome. Cell Commun Signal. 12:412014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Poalas K, Hatchi EM, Cordeiro N, Dubois
SM, Leclair HM, Leveau C, Alexia C, Gavard J, Vazquez A and Bidère
N: Negative regulation of NF-κB signaling in T lymphocytes by the
ubiquitin-specific protease USP34. Cell Commun Signal. 11:252013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao S, Tian Y, Zhang W, Xing X, Li T, Liu
H, Huang T, Ning Y, Zhao H and Chen ZJ: An association study
between USP34 and polycystic ovary syndrome. J Ovarian Res.
8:302015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mimouni-Bloch A, Yeshaya J, Kahana S, Maya
I and Basel-Vanagaite L: A de-novo interstitial microduplication
involving 2p16.1-p15 and mirroring 2p16.1-p15 microdeletion
syndrome: Clinical and molecular analysis. Eur J Paediatr Neurol.
19:711–715. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kwiecinska A, Ichimura K, Berglund M,
Dinets A, Sulaiman L, Collins VP, Larsson C, Porwit A and
Lagercrantz SB: Amplification of 2p as a genomic marker for
transformation in lymphoma. Genes Chromosomes Cancer. 53:750–768.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Scholtysik R, Kreuz M, Hummel M,
Rosolowski M, Szczepanowski M, Klapper W, Loeffler M, Trümper L,
Siebert R and Küppers R; Molecular Mechanisms in Malignant
Lymphomas Network Project of the Deutsche Krebshilfe, :
Characterization of genomic imbalances in diffuse large B-cell
lymphoma by detailed SNP-chip analysis. Int J Cancer.
136:1033–1042. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Taskinen M, Louhimo R, Koivula S, Chen P,
Rantanen V, Holte H, Delabie J, Karjalainen-Lindsberg ML, Björkholm
M, Fluge Ø, et al: Deregulation of COMMD1 is associated with poor
prognosis in diffuse large B-cell lymphoma. PLoS One. 9:e910312014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Trifonov V, Pasqualucci L, Dalla Favera R
and Rabadan R: MutComFocal: An integrative approach to identifying
recurrent and focal genomic alterations in tumor samples. BMC Syst
Biol. 7:252013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mo CH, Gao L, Zhu XF, Wei KL, Zeng JJ,
Chen G and Feng ZB: The clinicopathological significance of UBE2C
in breast cancer: A study based on immunohistochemistry, microarray
and RNA-sequencing data. Cancer Cell Int. 17:832017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Boustani MR, Khoshnood RJ, Nikpasand F,
Taleshi Z, Ahmadi K, Yahaghi E and Goudarzi PK: Overexpression of
ubiquitin-specific protease 2a (USP2a) and nuclear factor erythroid
2-related factor 2 (Nrf2) in human gliomas. J Neurol Sci.
363:249–252. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Y, Liu Y, Yang B, Cao H, Yang CX,
Ouyang W, Zhang SM, Yang GF, Zhou FX, Zhou YF and Xie CH: Elevated
expression of USP9X correlates with poor prognosis in human
non-small cell lung cancer. J Thorac Dis. 7:672–679.
2015.PubMed/NCBI
|
|
26
|
Wang Z, Zhu L, Guo T, Wang Y and Yang J:
Decreased H2B monoubiquitination and overexpression of
ubiquitin-specific protease enzyme 22 in malignant colon carcinoma.
Hum Pathol. 46:1006–1014. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang B, Tang F, Li B, Yuan S, Xu Q,
Tomlinson S, Jin J, Hu W and He S: High USP22 expression indicates
poor prognosis in hepatocellular carcinoma. Oncotarget.
6:12654–12667. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ning Z, Wang A, Liang J, Xie Y, Liu J,
Feng L, Yan Q and Wang Z: USP22 promotes the G1/S phase transition
by upregulating FoxM1 expression via β-catenin nuclear localization
and is associated with poor prognosis in stage II pancreatic ductal
adenocarcinoma. Int J Oncol. 45:1594–1608. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ao N and Liu Y, Bian X, Feng H and Liu Y:
Ubiquitin-specific peptidase 22 inhibits colon cancer cell invasion
by suppressing the signal transducer and activator of transcription
3/matrix metalloproteinase 9 pathway. Mol Med Rep. 12:2107–2113.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang L, Xu B, Qiang Y, Huang H, Wang C,
Li D and Qian J: Overexpression of deubiquitinating enzyme USP28
promoted non-small cell lung cancer growth. J Cell Mol Med.
19:799–805. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao Y, Zhang B, Lei Y, Sun J, Zhang Y,
Yang S and Zhang X: Knockdown of USP39 induces cell cycle arrest
and apoptosis in melanoma. Tumour Biol. 37:13167–13176. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Colomo L, Lopez-Guillermo A, Perales M,
Rives S, Martínez A, Bosch F, Colomer D, Falini B, Montserrat E and
Campo E: Clinical impact of the differentiation profile assessed by
immunophenotyping in patients with diffuse large B-cell lymphoma.
Blood. 101:78–84. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liao W: Different expression status of
apoptosis related proteins Fas, FasL, Bcl-2 and survivin in GCB and
non-GCB immuno-subtypes of diffuse large B-cell lymphoma in
Guangxi, China. unpublished PhD thesisGuangxi Medical University;
2012
|
|
34
|
Gan TQ, Xie ZC, Tang RX, Zhang TT, Li DY,
Li ZY and Chen G: Clinical value of miR-145-5p in NSCLC and
potential molecular mechanism exploration: A retrospective study
based on GEO, qRT-PCR and TCGA data. Tumour Biol.
39:10104283176916832017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang X, Ye ZH, Liang HW, Ren FH, Li P,
Dang YW and Chen G: Down-regulation of miR-146a-5p and its
potential targets in hepatocellular carcinoma validated by a TCGA-
and GEO-based study. FEBS Open Bio. 7:504–521. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wei DM, Chen ZX, He RQ, Shi L, Zhou S, Li
W, Chen G, Peng Z, Dang Y and Luo D: Genomic alterations andprotein
expression of STAT4 in pancreatic cancer: A study of bioinformatics
based on public data and immunohistochemistry validation with 241
tissue samples. Int J Clin Exp Pathol. 9:9761–9774. 2016.
|
|
37
|
Kubuschok B, Held G and Pfreundschuh M:
Management of diffuse large B-cell lymphoma (DLBCL). Cancer Treat
Res. 165:271–288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Walker MP, Stopford CM, Cederlund M, Fang
F, Jahn C, Rabinowitz AD, Goldfarb D, Graham DM, Yan F, Deal AM, et
al: FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B
cell lymphoma. Sci Signal. 8:ra122015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang Y, Kelly P, Shaffer AL III, Schmitz
R, Yoo HM, Liu X, Huang DW, Webster D, Young RM, Nakagawa M, et al:
Targeting non-proteolytic protein ubiquitination for the treatment
of diffuse large B cell lymphoma. Cancer Cell. 29:494–507. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Choe JY, Park M, Yun JY, Na HY, Go H, Kim
HJ, Oh S and Kim JE: PELI1 expression is correlated with MYC and
BCL6 expression and associated with poor prognosis in diffuse large
B-cell lymphoma. Mod Pathol. 29:1313–1323. 2016. View Article : Google Scholar : PubMed/NCBI
|
